Researchers at the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) have uncovered a novel signalling pathway triggered by a protein called FUT1 to promote cancer stemness, contributing to drug resistance and tumour recurrence of liver c
A research team from the Department of Applied Biology and Chemical Technology (ABCT) of The Hong Kong Polytechnic University (PolyU) has developed a novel type of biomimetic nanosheet with a multi-modal imaging function, which can track tumour devel
Hong Kong unveils next-gen drug for cancers associated with EpsteinâBarr virus
Hong Kong unveils next-gen drug for cancers associated with EpsteinâBarr virus 03 March 2021 | News HKBU has established a spin-off company named BP InnoMed Limited (BPI) to further develop this new anti-EBV drug and carry out clinical trials
Source: PR Newswire
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein–Barr virus (EBV).
The peptide-linked drug, which is responsive to the acidic environment found in tumours, is the first known agent to have successfully targeted two viral proteins that are simultaneously produced by EBV.
CSIR–IICT licenses novel fluorophores tech to Tokyo Chemical Industry
February 05, 2021
Most of the raw materials used in the research made indigenously
The CSIR-Indian Institute of Chemical Technology (CSIR-IICT) has licensed the novel fluorophores technology to Tokyo Chemical Industry (TCI) CO Ltd, Japan.
The technology has been developed by scientist Surya Prakash Singh’s group at the CSIR-IICT. Singh works in the department of Polymers and Functional Materials and his major research focuses on the design and synthesis of various classes of sustainable dyes for their use in photonic devices, textiles, paints, and other biological applications.
Cellular powerhouses
“Most of the raw materials used in making such novel fluorophores are indigenously made, thus supporting government’s initiatives on Atmanirbhar Bharat,’’ the Hyderabad-based IICT said in a release.